The Summit
26th - 28th April 2010
Summit Venue
The Boulders Resort, Scottsdale, Arizona
The Next Generation Pharmaceutical Summit has grown to become the standard for senior level pharmaceutical executives looking to share ideas with peers, build partnerships with industry thought leaders, and hear from key experts on how to address some of their most pressing challenges in discovery and development, clinical research and beyond.
Past and Present VIP Attendees
VP of Global Clinical Research Operations
Pfizer Inc.
Chief Infectious Disease
NIH
VP of Clinical Development, Oncology
sanofi-aventis
VP Clinical Development
Celgene
VP Clinical Sciences & Study Operations
GSK
SVP Medical & Scientific Affairs
Takeda Pharmaceuticals
VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.
SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb
VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb
VP Early Drug Development
Celgene
VP of Discovery Medicine
GSK
VP Translational Medicine & Pharmacogenomics
Eli Lilly
Global Head Oncology Clinical Imaging
Novartis
Chief Medical Officer and SVP
Schering-Plough Corporation
SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation
VP Early Development and Clinical Pharmacology
Wyeth
Assistant VP Translational Medicine
Wyeth
Group Vice President of Global Clinical Research
Schering-Plough Corporation
COO and SVP of Research and Development
Biolex
VP of Global Clinical Research Operations
Pfizer Inc.
Chief Infectious Disease
NIH
VP of Clinical Development, Oncology
sanofi-aventis
VP Clinical Development
Celgene
VP Clinical Sciences & Study Operations
GSK
SVP Medical & Scientific Affairs
Takeda Pharmaceuticals
VP Clinical Research
Boehringer Ingelheim Pharmaceuticals, Inc.
SVP Discovery and Exploratory Clinical Research
Bristol Myers-Squibb
VP Global Pharmacovigilance & Epidemiology – Medical Safety
Bristol-Myers Squibb
VP Early Drug Development
Celgene
VP of Discovery Medicine
GSK
VP Translational Medicine & Pharmacogenomics
Eli Lilly
Global Head Oncology Clinical Imaging
Novartis
Chief Medical Officer and SVP
Schering-Plough Corporation
SVP Discovery Research and Chief Scientific Officer
Schering-Plough Corporation
VP Early Development and Clinical Pharmacology
Wyeth
Assistant VP Translational Medicine
Wyeth
Group Vice President of Global Clinical Research
Schering-Plough Corporation
COO and SVP of Research and Development
Biolex
Summit Update
Get the latest summit news sent to your email or mobile.
Roundtables
Roundtables and Panel Discussions offer moderated, peer-led discussion on major industry issues.
The moderator or discussion leader will present an issue to the table, and to the audience. The issue will be relevant to all attendees, and the session should provide key insights and learnings (details of which are available in the event guide).
The moderator will choose the topics under discussion. That said, if you have an idea you think would be perfect for this type of forum, then let us know.
Roundtables and Panel Discussions will run for a minimum of 40 minutes. At least ten minutes will be dedicated to questions from the floor, giving all attendees an opportunity for interaction and a chance to create dialogue between themselves, their peers and the industry leader.
Testimonials
"I think the model for this conference is terrific. It was very enjoyable."
Alexander Kamb, Amgen
Source: www.ngpsummit.com© 2010 GDS International Ltd. All rights reserved.